Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 3764372, 10 pages
http://dx.doi.org/10.1155/2016/3764372
Research Article

Activation of the Extracellular Signal-Regulated Kinase Signaling Is Critical for Human Umbilical Cord Mesenchymal Stem Cell Osteogenic Differentiation

1Key Laboratory of Shaanxi Province for Craniofacial Precision Medicine Research, College of Stomatology, Xi’an Jiaotong University, Xi’an, Shaanxi 710004, China
2Department of Orthodontics, College of Stomatology, Xi’an Jiaotong University, Xi’an, Shaanxi 710004, China
3Division of Growth and Development and Section of Orthodontics, School of Dentistry, University of California, Los Angeles, CA 90095, USA
4University of Chicago, Chicago, IL 60637, USA

Received 22 October 2015; Revised 15 January 2016; Accepted 21 January 2016

Academic Editor: Martin Sebastian Staege

Copyright © 2016 Chen-Shuang Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. N. Rahaman and J. J. Mao, “Stem cell-based composite tissue constructs for regenerative medicine,” Biotechnology and Bioengineering, vol. 91, no. 3, pp. 261–284, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. K. Wieser, P. Zingg, and C. Dora, “Trochanteric osteotomy in primary and revision total hip arthroplasty: risk factors for non-union,” Archives of Orthopaedic and Trauma Surgery, vol. 132, no. 5, pp. 711–717, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. X. Wang, Y. Wang, W. Gou, Q. Lu, J. Peng, and S. Lu, “Role of mesenchymal stem cells in bone regeneration and fracture repair: a review,” International Orthopaedics, vol. 37, no. 12, pp. 2491–2498, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. A. R. Amini, C. T. Laurencin, and S. P. Nukavarapu, “Bone tissue engineering: recent advances and challenges,” Critical Reviews in Biomedical Engineering, vol. 40, no. 5, pp. 363–408, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Ohishi and E. Schipani, “Bone marrow mesenchymal stem cells,” Journal of Cellular Biochemistry, vol. 109, no. 2, pp. 277–282, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. E. A. Jones, S. E. Kinsey, A. English et al., “Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells,” Arthritis and Rheumatism, vol. 46, no. 12, pp. 3349–3360, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. D. Dallari, M. Fini, C. Stagni et al., “In vivo study on the healing of bone defects treated with bone marrow stromal cells, platelet-rich plasma, and freeze-dried bone allografts, alone and in combination,” Journal of Orthopaedic Research, vol. 24, no. 5, pp. 877–888, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Y. Lee, M. Miwa, Y. Sakai et al., “In vitro multipotentiality and characterization of human unfractured traumatic hemarthrosis-derived progenitor cells: a potential cell source for tissue repair,” Journal of Cellular Physiology, vol. 210, no. 3, pp. 561–566, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Bobis, D. Jarocha, and M. Majka, “Mesenchymal stem cells: characteristics and clinical applications,” Folia Histochemica et Cytobiologica, vol. 44, no. 4, pp. 215–230, 2006. View at Google Scholar · View at Scopus
  10. C. Zhou, B. Yang, Y. Tian et al., “Immunomodulatory effect of human umbilical cord Wharton's jelly-derived mesenchymal stem cells on lymphocytes,” Cellular Immunology, vol. 272, no. 1, pp. 33–38, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. H. He, T. Nagamura-Inoue, A. Takahashi et al., “Immunosuppressive properties of Wharton’s jelly-derived mesenchymal stromal cells in vitro,” International Journal of Hematology, vol. 102, no. 3, pp. 368–378, 2015. View at Publisher · View at Google Scholar
  12. L.-L. Lu, Y.-J. Liu, S.-G. Yang et al., “Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials,” Haematologica, vol. 91, no. 8, pp. 1017–1028, 2006. View at Google Scholar · View at Scopus
  13. M. B. Dehkordi, Z. Madjd, M. H. Chaleshtori, R. Meshkani, L. Nikfarjam, and A. Kajbafzadeh, “A simple, rapid, and efficient method for isolating mesenchymal stem cells from the entire umbilical cord,” Cell Transplantation.
  14. M. L. Weiss, S. Medicetty, A. R. Bledsoe et al., “Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease,” STEM CELLS, vol. 24, no. 3, pp. 781–792, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. M. T. Conconi, P. Burra, R. Di Liddo et al., “CD105(+) cells from Wharton's jelly show in vitro and in vivo myogenic differentiative potential,” International Journal of Molecular Medicine, vol. 18, no. 6, pp. 1089–1096, 2006. View at Google Scholar · View at Scopus
  16. A. Can and S. Karahuseyinoglu, “Concise review: human umbilical cord stroma with regard to the source of fetus-derived stem cells,” Stem Cells, vol. 25, no. 11, pp. 2886–2895, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Subramanian, S.-U. Gan, K.-S. Ngo et al., “Human umbilical cord Wharton's jelly mesenchymal stem cells do not transform to tumor-associated fibroblasts in the presence of breast and ovarian cancer cells unlike bone marrow mesenchymal stem cells,” Journal of Cellular Biochemistry, vol. 113, no. 6, pp. 1886–1895, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Sarugaser, D. Lickorish, D. Baksh, M. M. Hosseini, and J. E. Davies, “Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors,” Stem Cells, vol. 23, no. 2, pp. 220–229, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. D. Baksh, R. Yao, and R. S. Tuan, “Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow,” Stem Cells, vol. 25, no. 6, pp. 1384–1392, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. N. Hjortholm, E. Jaddini, K. Hałaburda, and E. Snarski, “Strategies of pain reduction during the bone marrow biopsy,” Annals of Hematology, vol. 92, no. 2, pp. 145–149, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. P. A. Sotiropoulou, S. A. Perez, M. Salagianni, C. N. Baxevanis, and M. Papamichail, “Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells,” Stem Cells, vol. 24, no. 2, pp. 462–471, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Bosch, A. P. Houben, T. F. Radke et al., “Distinct differentiation potential of ‘mSC’ derived from cord blood and umbilical cord: Are cord-derived cells true mesenchymal stromal cells?” Stem Cells and Development, vol. 21, no. 11, pp. 1977–1988, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Leeb, M. Jurga, C. McGuckin, R. Moriggl, and L. Kenner, “Promising new sources for pluripotent stem cells,” Stem Cell Reviews and Reports, vol. 6, no. 1, pp. 15–26, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Latifpour, S. N. Nematollahi-Mahani, M. Deilamy et al., “Improvement in cardiac function following transplantation of human umbilical cord matrix-derived mesenchymal cells,” Cardiology, vol. 120, no. 1, pp. 9–18, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Sypecka and A. Sarnowska, “Mesenchymal cells of umbilical cord and umbilical cord blood as a source of human oligodendrocyte progenitors,” Life Sciences, vol. 139, pp. 24–29, 2015. View at Publisher · View at Google Scholar
  26. C. Nan, Y. Shi, Z. Zhao et al., “Monosialoteterahexosyl ganglioside induces the differentiation of human umbilical cord-derived mesenchymal stem cells into neuron-like cells,” International Journal of Molecular Medicine, pp. 1057–1062, 2015. View at Publisher · View at Google Scholar
  27. M. E. Klontzas, E. I. Kenanidis, M. Heliotis, E. Tsiridis, and A. Mantalaris, “Bone and cartilage regeneration with the use of umbilical cord mesenchymal stem cells,” Expert Opinion on Biological Therapy, vol. 15, no. 11, pp. 1541–1552, 2015. View at Publisher · View at Google Scholar
  28. Z.-Y. Guo, X. Sun, X.-L. Xu, J. Peng, and Y. Wang, “Human umbilical cord mesenchymal stem cells promote peripheral nerve repair via paracrine mechanisms,” Neural Regeneration Research, vol. 10, no. 4, pp. 651–658, 2015. View at Publisher · View at Google Scholar
  29. R. A. Hipskind and G. Bilbe, “MAP kinase signaling cascades and gene expression in osteoblasts,” Frontiers in Bioscience, vol. 3, pp. d804–d816, 1998. View at Google Scholar
  30. N. Blüthgen and S. Legewie, “Systems analysis of MAPK signal transduction,” Essays in Biochemistry, vol. 45, pp. 95–107, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. L. Fu, T. Tang, Y. Miao, S. Zhang, Z. Qu, and K. Dai, “Stimulation of osteogenic differentiation and inhibition of adipogenic differentiation in bone marrow stromal cells by alendronate via ERK and JNK activation,” Bone, vol. 43, no. 1, pp. 40–47, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. R. K. Jaiswal, N. Jaiswal, S. P. Bruder, G. Mbalaviele, D. R. Marshak, and M. F. Pittenger, “Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase,” The Journal of Biological Chemistry, vol. 275, no. 13, pp. 9645–9652, 2000. View at Publisher · View at Google Scholar · View at Scopus
  33. Q. Liu, L. Cen, H. Zhou et al., “The role of the extracellular signal-related kinase signaling pathway in osteogenic differentiation of human adipose-derived stem cells and in adipogenic transition initiated by dexamethasone,” Tissue Engineering Part: A, vol. 15, no. 11, pp. 3487–3497, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. F.-H. Lin, J. B. Chang, and B. E. Brigman, “Role of mitogen-activated protein kinase in osteoblast differentiation,” Journal of Orthopaedic Research, vol. 29, no. 2, pp. 204–210, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Suzuki, J. Guicheux, G. Palmer et al., “Evidence for a role of p38 MAP kinase in expression of alkaline phosphatase during osteoblastic cell differentiation,” Bone, vol. 30, no. 1, pp. 91–98, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Schindeler and D. G. Little, “Ras-MAPK signaling in osteogenic differentiation: friend or foe?” Journal of Bone and Mineral Research, vol. 21, no. 9, pp. 1331–1338, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. F. Wang, Y.-C. Zhang, H. Zhou, Y.-C. Guo, and X.-X. Su, “Evaluation of in vitro and in vivo osteogenic differentiation of nano-hydroxyapatite/chitosan/poly(lactide-co-glycolide) scaffolds with human umbilical cord mesenchymal stem cells,” Journal of Biomedical Materials Research Part: A, vol. 102, no. 3, pp. 760–768, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. J. V. Duncia, J. B. Santella III, C. A. Higley et al., “MEK inhibitors: the chemistry and biological activity of U0126, its analogs, and cyclization products,” Bioorganic and Medicinal Chemistry Letters, vol. 8, no. 20, pp. 2839–2844, 1998. View at Publisher · View at Google Scholar · View at Scopus
  39. K. J. Livak and T. D. Schmittgen, “Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method,” Methods, vol. 25, no. 4, pp. 402–408, 2001. View at Publisher · View at Google Scholar · View at Scopus
  40. J. Shen, A. W. James, J. Chung et al., “NELL-1 promotes cell adhesion and differentiation via Integrinβ1,” Journal of Cellular Biochemistry, vol. 113, no. 12, pp. 3620–3628, 2012. View at Publisher · View at Google Scholar
  41. A. Plotnikov, E. Zehorai, S. Procaccia, and R. Seger, “The MAPK cascades: signaling components, nuclear roles and mechanisms of nuclear translocation,” Biochimica et Biophysica Acta (BBA)—Molecular Cell Research, vol. 1813, no. 9, pp. 1619–1633, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. H. S. Jung, Y. H. Kim, and J. W. Lee, “Duration and magnitude of extracellular signal-regulated protein kinase phosphorylation determine adipogenesis or osteogenesis in human bone marrow-derived stem cells,” Yonsei Medical Journal, vol. 52, no. 1, pp. 165–172, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. T. K. P. Doan, K. S. Park, H. K. Kim, D. S. Park, J. H. Kim, and T. R. Yoon, “Inhibition of JNK and ERK pathways by SP600125-and U0126-enhanced osteogenic differentiation of bone marrow stromal cells,” Tissue Engineering and Regenerative Medicine, vol. 9, no. 6, pp. 283–294, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. J. Caverzasio and D. Manen, “Essential role of Wnt3a-mediated activation of mitogen-activated protein kinase p38 for the stimulation of alkaline phosphatase activity and matrix mineralization in C3H10T1/2 mesenchymal cells,” Endocrinology, vol. 148, no. 11, pp. 5323–5330, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. A. K. Kundu, C. B. Khatiwala, and A. J. Putnam, “Extracellular matrix remodeling, integrin expression, and downstream signaling pathways influence the osteogenic differentiation of mesenchymal stem cells on poly(Lactide-co-glycolide) substrates,” Tissue Engineering Part: A, vol. 15, no. 2, pp. 273–283, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. A. Suzuki, Á. Raya, Y. Kawakami et al., “Nanog binds to Smad1 and blocks bone morphogenetic protein-induced differentiation of embryonic stem cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 27, pp. 10294–10299, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. Y. Hu, E. Chan, S. X. Wang, and B. Li, “Activation of p38 mitogen-activated protein kinase is required for osteoblast differentiation,” Endocrinology, vol. 144, no. 5, pp. 2068–2074, 2003. View at Publisher · View at Google Scholar · View at Scopus
  48. J. Guicheux, J. Lemonnier, C. Ghayor, A. Suzuki, G. Palmer, and J. Caverzasio, “Activation of p38 mitogen-activated protein kinase and c-Jun-NH2-terminal kinase by BMP-2 and their implication in the stimulation of osteoblastic cell differentiation,” Journal of Bone and Mineral Research, vol. 18, no. 11, pp. 2060–2068, 2003. View at Publisher · View at Google Scholar · View at Scopus
  49. O. Kozawa, D. Hatakeyama, and T. Uematsu, “Divergent regulation by p44/p42 MAP kinase and p38 MAP kinase of bone morphogenetic protein-4-stimulated osteocalcin synthesis in osteoblasts,” Journal of Cellular Biochemistry, vol. 84, no. 3, pp. 583–589, 2001. View at Publisher · View at Google Scholar · View at Scopus
  50. K. A. Payne, L. B. Meszaros, J. A. Phillippi, and J. Huard, “Effect of phosphatidyl inositol 3-kinase, extracellular signal-regulated kinases 1/2, and p38 mitogen-activated protein kinase inhibition on osteogenic differentiation of muscle-derived stem cells,” Tissue Engineering Part A, vol. 16, no. 12, pp. 3647–3655, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. S. Peng, G. Zhou, K. D. K. Luk et al., “Strontium promotes osteogenic differentiation of mesenchymal stem cells through the Ras/MAPK signaling pathway,” Cellular Physiology and Biochemistry, vol. 23, no. 1–3, pp. 165–174, 2009. View at Publisher · View at Google Scholar · View at Scopus
  52. H. Liu, Y. Liu, M. Viggeswarapu, Z. Zheng, L. Titus, and S. D. Boden, “Activation of c-Jun NH2-terminal kinase 1 increases cellular responsiveness to BMP-2 and decreases binding of inhibitory Smad6 to the type 1 BMP receptor,” Journal of Bone and Mineral Research, vol. 26, no. 5, pp. 1122–1132, 2011. View at Publisher · View at Google Scholar · View at Scopus
  53. K. Sullivan, J. El-Hoss, D. G. Little, and A. Schindeler, “JNK inhibitors increase osteogenesis in Nf1-deficient cells,” Bone, vol. 49, no. 6, pp. 1311–1316, 2011. View at Publisher · View at Google Scholar · View at Scopus
  54. C. Higuchi, A. Myoui, N. Hashimoto et al., “Continuous inhibition of MAPK signaling promotes the early osteoblastic differentiation and mineralization of the extracellular matrix,” Journal of Bone and Mineral Research, vol. 17, no. 10, pp. 1785–1794, 2002. View at Publisher · View at Google Scholar · View at Scopus
  55. W. X. Wang, J. S. Nyman, K. Ono, D. A. Stevenson, X. Yang, and F. Elefteriou, “Mice lacking Nf1 in osteochondroprogenitor cells display skeletal dysplasia similar to patients with neurofibromatosis type I,” Human Molecular Genetics, vol. 20, no. 20, pp. 3910–3924, 2011. View at Publisher · View at Google Scholar · View at Scopus
  56. L. R. Chaudhary and L. V. Avioli, “Activation of extracellular signal-regulated kinases 1 and 2 (ERK1 and ERK2) by FGF-2 and PDGF-BB in normal human osteoblastic and bone marrow stromal cells: differences in mobility and in-gel renaturation of ERK1 in human, rat, and mouse osteoblastic cells,” Biochemical and Biophysical Research Communications, vol. 238, no. 1, pp. 134–139, 1997. View at Publisher · View at Google Scholar · View at Scopus
  57. P. Salehinejad, N. Banu Alitheen, A. M. Ali et al., “Comparison of different methods for the isolation of mesenchymal stem cells from human umbilical cord Wharton's jelly,” In Vitro Cellular and Developmental Biology—Animal, vol. 48, no. 2, pp. 75–83, 2012. View at Publisher · View at Google Scholar · View at Scopus
  58. R. C. Schugar, B. M. Deasy, S. M. Chirieleison et al., “High harvest yield, high expansion, and phenotype stability of CD146 mesenchymal stromal cells from whole primitive human umbilical cord tissue,” Journal of Biomedicine and Biotechnology, vol. 2009, Article ID 789526, 11 pages, 2009. View at Publisher · View at Google Scholar · View at Scopus